BioDesign_Protein drug design platform

BioDesign_Protein drug design platform

De novo protein drug design, Affinity modulation, Epitope-specific antibody design, Fc engineering.


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
South Korea
Payment Terms
Others
Production method
Available
Shipping / Lead Time
Negotiable / Negotiable
Keyword
antibody, innovation, protein, drug design
Category
Medicines

Galux Inc.

Membership
PRO
Country / Year Established
South Korea South Korea / 2020
Business type
Others
Verified Certificate

1

DUNS

Product name BioDesign_Protein drug design platform Certification -
Category Medicines Material -
Keyword antibody , innovation , protein , drug design Unit Size -
Brand name - Unit Weigh -
origin South Korea Stock 999999
Supply type Available HS code -

Product Information

BioDesign is capable of desinging a protein drug (e.g. antibody, cytokine) against a molecular target of interest.

 

Currently capable of:

  • Affinity modulation through insertion/deletion/substitution of amino acids.
  • Affinity modulation in a pH-conditioned manner - Can modulate a protein drug to exclusively interact with its target only in a certain pH level (e.g. acidic condition).
  • Fc engineering to elicit select desired effector function of an antibody while suppressing other effector function.

Under development:

  • Epitope-specific antibody design.
  • Modulating the Fc region of an antibody to function like a Fab region and bind to an antigen. This would allow the design of unconventional bi-specific (one epitope with Fab region and another with Fc region) and even tri-specific antibodies.

Our AI learns the physical principles of protein folding and interaction and we incorporate real-world experimental data into its learning process. This enables the AI to cross-reference its theoretical understanding of physics with emperical data allowing it to generate an accurate picture or representation of the protein structure and interection.

 

B2B Trade

Price (FOB) Negotiable transportation Negotiation Other
MOQ Negotiable Leadtime Negotiable
Payment Options Others Shipping time Negotiable

Galux Inc.

Country / Year Established
South Korea South Korea / 2020
Membership
PRO
Business type
Others

1

DUNS

President
Product Category
Medicines,Other Pharmaceuticals
Year Established
2020
Main Markets

France France

Germany Germany

Japan Japan

U. Kingdom U. Kingdom

U.S.A U.S.A

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more